Vials sold online as "research peptides" are not manufactured to pharmaceutical standards, are not intended for human use, and their purity and dosing accuracy cannot be assumed
October 2023 : A study of 16 million patients (2006-2020) found that those who used GLP-1 agonists for weight loss were at a higher risk of pancreatitis, bowel obstruction, and gastroparesis compared to those who took bupropion-naltrexone instead
In addition, considering the important concept, cytoprotection (initially based on the essential consistent ulcerogenic role of NSAIDs agents (25)) can now provide the consistently demonstrated NSAIDs-sphincter failure as an additional clue to further accommodate all of the NSAIDs effects
If you experience severe abdominal pain that does not go away, as this may indicate pancreatitis
GLP-1 is also a central regulator of hunger and reward pathways in the brain, which is where its role in addiction is starting to become clearer
This mechanism reduces blood glucose levels in people with type 2 diabetes and promotes satiety, contributing to weight loss